• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial-Eligible Populations.

作者信息

Dayal Parul, Iribarren Carlos, Cheung Dorothy, Rothenberg Michael E, Spain C Victor

机构信息

Genentech Inc. South San Francisco, California.

Kaiser Permanente Northern California Oakland, California.

出版信息

Ann Am Thorac Soc. 2021 Sep;18(9):1580-1584. doi: 10.1513/AnnalsATS.202010-1349RL.

DOI:10.1513/AnnalsATS.202010-1349RL
PMID:33606957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8489874/
Abstract
摘要

相似文献

1
Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial-Eligible Populations.重度哮喘患者的主要心血管事件发生率：美国真实世界及符合临床试验条件的人群
Ann Am Thorac Soc. 2021 Sep;18(9):1580-1584. doi: 10.1513/AnnalsATS.202010-1349RL.
2
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma.接受奥马珠单抗治疗的患者中的心血管和脑血管事件：来自 EXCELS 的结果，一项中度至重度哮喘的前瞻性队列研究。
J Allergy Clin Immunol. 2017 May;139(5):1489-1495.e5. doi: 10.1016/j.jaci.2016.07.038. Epub 2016 Sep 14.
3
For a patient with severe asthma, every day may be his last World Asthma Day.
Pulmonology. 2021 May-Jun;27(3):279-280. doi: 10.1016/j.pulmoe.2020.05.009. Epub 2020 Nov 5.
4
Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base.美泊利单抗对重度哮喘急性加重的影响：来自美国保险理赔数据库的结果
Allergy Asthma Proc. 2020 Sep 1;41(5):341-347. doi: 10.2500/aap.2020.41.200043.
5
World Asthma Day. GINA 2014: a global asthma strategy for a global problem.世界哮喘日。《2014年全球哮喘防治创议》：针对全球性问题的全球哮喘防治策略。
Int J Tuberc Lung Dis. 2014 May;18(5):505-6. doi: 10.5588/ijtld.14.0246.
6
A framework for achieving better asthma control: introducing two new series in the journal.实现更好哮喘控制的框架：在该期刊推出两个新系列。
Int J Tuberc Lung Dis. 2006 Feb;10(2):124.
7
Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study.重度哮喘真实世界患者的生物治疗适用性：理想研究
J Asthma. 2018 Feb;55(2):152-160. doi: 10.1080/02770903.2017.1322611. Epub 2017 Jun 16.
8
[Asthma symptoms and anti-asthma drugs in 4 Scandinavian countries].[4个斯堪的纳维亚国家的哮喘症状与抗哮喘药物]
Nord Med. 1996 May;111(5):147-50.
9
[Beta blockers in asthma and COPD--a therapeutic dilemma?].[β受体阻滞剂在哮喘和慢性阻塞性肺疾病中的应用——一个治疗难题？]
Pneumologie. 2001 Feb;55(2):53-6. doi: 10.1055/s-2001-11289.
10
Persistent severe asthma and aging: step-up therapy with omalizumab to improve control.持续性重度哮喘与衰老：使用奥马珠单抗强化治疗以改善控制情况
Ann Allergy Asthma Immunol. 2010 Dec;105(6):408-10. doi: 10.1016/j.anai.2010.09.013.

引用本文的文献

1
Cardiovascular safety of biologic therapies in patients with severe asthma: a nationwide cohort study in Belgium.重度哮喘患者生物治疗的心血管安全性：比利时一项全国性队列研究
Lancet Reg Health Eur. 2025 Aug 6;57:101420. doi: 10.1016/j.lanepe.2025.101420. eCollection 2025 Oct.

本文引用的文献

1
Asthma and risk of coronary heart disease: A meta-analysis of cohort studies.哮喘与冠心病风险：队列研究的荟萃分析
Ann Allergy Asthma Immunol. 2017 Jun;118(6):689-695. doi: 10.1016/j.anai.2017.03.012. Epub 2017 Apr 19.
2
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma.接受奥马珠单抗治疗的患者中的心血管和脑血管事件：来自 EXCELS 的结果，一项中度至重度哮喘的前瞻性队列研究。
J Allergy Clin Immunol. 2017 May;139(5):1489-1495.e5. doi: 10.1016/j.jaci.2016.07.038. Epub 2016 Sep 14.
3
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.关于随机对照试验样本代表性及其对试验结果外部有效性影响的文献综述。
Trials. 2015 Nov 3;16:495. doi: 10.1186/s13063-015-1023-4.
4
A rule of thumb for estimating the lower confidence interval in trials with small event rates.一种用于估计小事件发生率试验中置信区间下限的经验法则。
Anaesthesia. 2015 Aug;70(8):1008-10. doi: 10.1111/anae.13169.
5
Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis.哮喘预示心血管疾病事件：动脉粥样硬化的多民族研究。
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1520-5. doi: 10.1161/ATVBAHA.115.305452. Epub 2015 Apr 23.
6
If a little bit is wrong, how much is alright? Interpreting the significance of small numerators in clinical trials.若有一点差错，那多大程度算合适？解读临床试验中小分子的意义。
Anaesthesia. 2015 Mar;70(3):249-52. doi: 10.1111/anae.12980. Epub 2014 Dec 23.
7
Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts.成人哮喘与冠心病、脑血管病和心力衰竭风险：2 项匹配队列的前瞻性研究。
Am J Epidemiol. 2012 Dec 1;176(11):1014-24. doi: 10.1093/aje/kws181. Epub 2012 Nov 8.
8
Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases.为合并症患者提供循证决策信息：慢性病临床试验中必要信息的可用性。
PLoS One. 2012;7(8):e41601. doi: 10.1371/journal.pone.0041601. Epub 2012 Aug 3.
9
Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.发表于高影响力综合医学期刊的随机对照试验的纳入标准：一项系统抽样综述
JAMA. 2007 Mar 21;297(11):1233-40. doi: 10.1001/jama.297.11.1233.
10
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?哮喘随机对照试验的外部效度：试验结果适用于哪些人？
Thorax. 2007 Mar;62(3):219-23. doi: 10.1136/thx.2006.066837. Epub 2006 Nov 14.